{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:34Z","timestamp":1786654114886,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014470","name":"Netherlands Heart Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018722","name":"Stichting Jaap Schouten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijcha.2026.101970","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:15:40Z","timestamp":1783919740000},"page":"101970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pathophysiological analysis of serially measured plasma biomarkers, remote monitoring and clinical events, in symptomatic patients with moderate to severe chronic heart failure"],"prefix":"10.1016","volume":"65","author":[{"given":"Y.","family":"Allach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Barry - Loncq","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.D.","family":"Clephas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Abou","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.","family":"Brunner-La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Handoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.P.","family":"van Halm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.J.","family":"van Kimmenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.M.A.","family":"Beeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcha.2026.101970_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14779072.2023.2177635","article-title":"The role of serial cardiac biomarkers in prognostication and risk prediction of chronic heart failure: additional scientific insights with hemodynamic feedback","volume":"21","author":"Allach","year":"2023","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"9","key":"10.1016\/j.ijcha.2026.101970_bb0010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2022.05.013","article-title":"Pathophysiologic processes and novel biomarkers associated with congestion in heart failure","volume":"10","author":"Pandhi","year":"2022","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcha.2026.101970_bb0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ehjdh\/ztad056","article-title":"Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure","volume":"4","author":"de Bakker","year":"2023","journal-title":"Eur. Heart J. Digit. Health"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-5273(03)00115-3","article-title":"Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure","volume":"93","author":"Bettencourt","year":"2004","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101970_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009555","article-title":"Temporal patterns of 14 blood biomarker candidates of cardiac remodeling in relation to prognosis of patients with chronic heart failure-the bio-SHiFT study","volume":"8","author":"Bouwens","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2026.101970_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","article-title":"Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the bio-SHiFT study","volume":"196","author":"van Boven","year":"2018","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101970_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCHEARTFAILURE.112.000129","article-title":"Prognostic value of changes in Galectin-3 levels over time in patients with heart failure data from CORONA and COACH","volume":"6","author":"van der Velde","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcha.2026.101970_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/eurjhf\/hfs006","article-title":"Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology","volume":"14","author":"Broch","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12471-019-01341-9","volume":"28","author":"Brugts","year":"2020","journal-title":"Neth. Hear. J."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101970_bb0055","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/ejhf.3303","article-title":"Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: design and rationale of the BioMEMS study","volume":"26","author":"Allach","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101970_bb0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cardfail.2025.04.014","article-title":"The association between serially measured circulating biomarker patterns and pulmonary artery pressures measured by invasive hemodynamic monitoring","volume":"32","author":"Barry-Loncq De Jong","year":"2026","journal-title":"J. Card. Fail."},{"issue":"10394","key":"10.1016\/j.ijcha.2026.101970_bb0060","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0070","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41598-022-06698-3","article-title":"Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (bio-SHiFT study)","volume":"12","author":"Klimczak-Tomaniak","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101970_bb0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"Castiglione","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.ijcha.2026.101970_bb0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.ijcha.2026.101970_bb0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ejhf.2664","article-title":"Congestion in heart failure: a circulating biomarker-based perspective. A review from the biomarkers working group of the Heart Failure Association","volume":"24","author":"Nunez","year":"2022","journal-title":"European Society of Cardiology, Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcha.2026.101970_bb0090","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00009-2022","article-title":"A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension","volume":"8","author":"Smits","year":"2022","journal-title":"ERJ Open Res."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101970_bb0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijcha.2026.101970_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcha.2026.101970_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15420\/cfr.2015.1.2.96","article-title":"Biomarker guided therapy in chronic heart failure","volume":"1","author":"Brunner-La Rocca","year":"2015","journal-title":"Card. Fail. Rev."},{"issue":"6","key":"10.1016\/j.ijcha.2026.101970_bb0110","first-page":"523","volume":"75","author":"TA","year":"2022","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","article-title":"Soluble ST2 in heart failure","volume":"14","author":"McCarthy","year":"2018","journal-title":"Heart Fail. Clin."},{"issue":"6","key":"10.1016\/j.ijcha.2026.101970_bb0140","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/ehf2.14120","article-title":"Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence","volume":"9","author":"Bracun","year":"2022","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2026.101970_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.772105","article-title":"The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction","volume":"8","author":"Guo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcha.2026.101970_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijcard.2019.09.032","article-title":"Insulin-like growth factor binding protein 2 predicts mortality risk in heart failure","volume":"300","author":"Barutaut","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2026.101970_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1152\/physiol.00003.2024","article-title":"New insights into IGF-1 signaling in the heart","volume":"39","author":"Lee","year":"2024","journal-title":"Physiology"},{"issue":"12","key":"10.1016\/j.ijcha.2026.101970_bb0135","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/s44161-022-00181-y","article-title":"Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure","volume":"1","author":"Zhang","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.ijcha.2026.101970_bb0145","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.amjcard.2014.08.018","article-title":"Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?","volume":"114","author":"Gandhi","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2026.101970_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejheart.2003.05.002","article-title":"Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure","volume":"6","author":"Yamazaki","year":"2004","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcha.2026.101970_bb0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases: regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101970_bb0160","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/eci.12479","article-title":"Prognosis of new-onset heart failure outpatients and collagen biomarkers","volume":"45","author":"Sanchis","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.ijcha.2026.101970_bb0165","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.7150\/ijms.8083","article-title":"Comparison the prognostic value of Galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure","volume":"11","author":"Chang","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.ijcha.2026.101970_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ejheart.2006.03.002","article-title":"Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure","volume":"8","author":"Braunschweig","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101970_bb0175","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ehf2.12728","article-title":"Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player","volume":"7","author":"Wesseling","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2026.101970_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.10.079","article-title":"High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: a multimarker strategy for risk stratification in chronic heart failure","volume":"277","author":"Aimo","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcha.2026.101970_bb0185","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2217\/bmm-2020-0722","article-title":"Evaluation of a multimarker panel in chronic heart failure: a 10-year follow-up","volume":"15","author":"Bauer","year":"2021","journal-title":"Biomark. Med"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726001041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:24:21Z","timestamp":1786652661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S2352906726001041"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101970","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological analysis of serially measured plasma biomarkers, remote monitoring and clinical events, in symptomatic patients with moderate to severe chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101970"}}